Literature DB >> 23306370

Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy.

Michela Meregaglia1, Lorenza Ferrara, Alessia Melegaro, Vittorio Demicheli.   

Abstract

Pertussis incidence in Piemonte (Italy) is now at the lowest level ever reached (0.85 per 100,000 in 2010) but the disease is still endemic in infants (54 per 100,000 in 2005-2010). Parental "cocoon" immunization has been proposed in some countries (i.e. United States, France) as a measure to protect newborns from serious pertussis outcomes. We assessed the number needed to vaccinate (NNV) to prevent hospital admissions in infants (<12 months) and the potential cost-effectiveness of this strategy in Piemonte. The NNV for parental immunization was at least 5000 to prevent one infant hospitalization in the latest epidemic cycle (2005-2010) at the cost of >€100,000. The "cocoon" programme leads to net costs from a National Health Service (NHS) perspective (ROI<1). In contexts of low incidence and without reliable data on a high parent-attributable infant risk, the parental "cocoon" programme is poorly efficient and very resource intensive in preventing pertussis in infants.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306370     DOI: 10.1016/j.vaccine.2012.12.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

2.  Analysis of measles-related hospitalizations in Tuscany from 2000 to 2014.

Authors:  E Berti; S Sollai; E Orlandini; L Galli; M DE Martino; E Chiappini
Journal:  Epidemiol Infect       Date:  2016-05-31       Impact factor: 4.434

3.  Pertussis in Italy: how to protect the "unprotectable"?

Authors:  Fabiana Fiasca; Stefano Necozione; Antonella Mattei
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.